Brown Brothers Harriman & Co. »

Neurobo Pharmaceuticals shares owned by Brown Brothers Harriman & Co.

Quarter-by-quarter ownership of Neurobo Pharmaceuticals (MTVA) shares owned by Brown Brothers Harriman & Co. from 13F filings

Historical chart of Brown Brothers Harriman & Co. investment in Neurobo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Neurobo Pharmaceuticals held by Brown Brothers Harriman & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurobo Pharmaceuticals by Brown Brothers Harriman & Co.

Quarter filed Position value Share count Share price at filing
2025-09-30 $24 27 0.93
2025-06-30 $16 27 0.63
2025-03-31 $42 27 1.56
2024-12-31 $54 27 2.04

More positions owned by Brown Brothers Harriman & Co.

Microsoft Corp Common Stock (MSFT)
Alphabet Inc-cl C Common Stock (GOOG)
Oracle Corp Common Stock (ORCL)
Ishares Core S&p 500 Etf Common Stock (IVV)
Kla Corp Common Stock (KLAC)
Berkshire Hathaway Inc-cl B Common Stock (BRK.B)
Apple Common Stock (AAPL)
Mastercard Inc - A Common Stock (MA)
Amazon.com Common Stock (AMZN)
Waste Management Common Stock (WM)
Linde Common Stock (LIN)
Booking Holdings Common Stock (BKNG)
Arthur J Gallagher & Co Common Stock (AJG)
Nvidia Corp Common Stock (NVDA)
Zoetis Common Stock (ZTS)

View all positions for Brown Brothers Harriman & Co.

Top funds holding Neurobo Pharmaceuticals

Vanguard Group
Geode Capital Management
SG Americas Securities
Jane Street
Two Sigma Securities
Virtu Financial
State Street Corporation
Northern Trust
Tower Research Capital
BlackRock
SBI Securities
UBS Group
Brown Brothers Harriman & Co.
Bnp Paribas Arbitrage, Snc

View all funds holding Neurobo Pharmaceuticals